...
机译:骨恶性淋巴瘤患者血清可溶性白细胞介素2受体水平
Department of Orthopaedic Surgery Shinshu University School of Medicine 3-1-1 Asahi Matsumoto 390-8621 Japan;
Department of Orthopaedic Surgery Shinshu University School of Medicine 3-1-1 Asahi Matsumoto 390-8621 Japan;
Department of Orthopaedic Surgery Shinshu University School of Medicine 3-1-1 Asahi Matsumoto 390-8621 Japan;
Department of Orthopaedic Surgery Shinshu University School of Medicine 3-1-1 Asahi Matsumoto 390-8621 Japan;
Department of Orthopaedic Surgery Shinshu University School of Medicine 3-1-1 Asahi Matsumoto 390-8621 Japan;
机译:骨恶性淋巴瘤患者的血清可溶性白介素2受体水平。
机译:血清可溶性白细胞介素2受体水平在原发性骨淋巴瘤中的可能临床意义:两例报告
机译:非霍奇金淋巴瘤患者血清可溶性白介素2受体α(sIL-2Ra)水平升高的临床意义
机译:多发性骨髓瘤骨病患者的破骨细胞的形成涉及可溶性诱饵受体3的分泌
机译:四种不同加工饮食对晚期糖糖末端产物(年龄),晚期糖糖末端产物(RAGE),血清和尿液代谢的血清受体水平的影响,以及健康犬的粪便微生物组
机译:血清可溶性白介素2受体水平用于恶性淋巴瘤的筛查和与其他疾病的鉴别诊断
机译:原发性骨淋巴瘤中血清可溶性白介素2受体水平的可能临床意义:2例报告